- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- ageddiagnostics.com
- Total Funding
- $700K
- Last Round
- Pre-SeedAug 2025
- Rounds
- 1
About
AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for the early detection and staging of liver disease. Its genomics-based assays detect circulating genetic signatures associated with conditions such as fibrosis and steatohepatitis (NASH) and liver cancer, aiming to give clinicians an earlier, more affordable alternative to biopsy and current screening methods so patients can access intervention sooner.
Summary
AGED Diagnostics is a Medtech company based in San Francisco, United States, founded in 2022. It has raised $700K in total across 1 round, most recently a Pre-Seed round in Aug 2025. Investors include TEDCO, Plug and Play and Central Texas Angel Network.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Aug 2025
Investors
Similar Companies

Clinical-stage medical technology company developing neural-engineering implants and platforms to...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...